← Eichor
Study identifier: NCT07725146 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Turkish Validation of the Rapprich Lipedema Symptomatic Assessment Questionnaire

Condition: Lipedema  ·  Sponsor: Marmara University

PhaseN/A
Planned participants180
Who can joinFemale, 18 Years to 75 Years
Healthy volunteersNo

About this study

Lipedema is a chronic disease characterized by abnormal fat accumulation, primarily in the lower extremities, affecting women. This study aims to evaluate the validity and reliability of the Turkish version of the Rapprich Lipedema Symptomatic Assessment Questionnaire, which was originally developed by Rapprich et al. in 2010. Since a validated Turkish version is currently unavailable, this research will provide a standardized tool for clinicians to assess symptomatic severity in Turkish-speaking lipedema patients.

This description comes directly from the study's public registry record.

Talk to the study team

Canan Şanal, Assoc. Prof.  ·  +90 533 138 10 32  ·  canansanal@hotmail.com

M. Selim Eryılmaz, Res. Asst.

Always discuss trial participation with your own doctor first.

Locations (2)

Sultan 2. Abdülhamid Han Training and Research Hospital, Physical Medicine and Rehabilitation Clinic, Istanbul, Turkey.Istanbul, Kadıköy, Turkey (Türkiye)Recruiting
Marmara University Pendik Training and Research Hospital, Physical Medicine and Rehabilitation Department, Istanbul, Turkey.Istanbul, Pendik, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07725146